Medicine Clinical Practice Guideline for MS / Neuromyelitis optica Spectrum Disorders 2023 / Japanese Society of Neurology / Preparation Committee for "Clinical Practice Guideline for MS / Neuromyelitis optica Spectrum Disorders"
![share weibo](http://service.weibo.com/share/share.php?url=https://www.suruga-ya.com/en/product/BO4001016&title=Clinical Practice Guideline for MS / Neuromyelitis optica Spectrum Disorders 2023 / Japanese Society of Neurology / Preparation Committee for "Clinical Practice Guideline for MS / Neuromyelitis optica Spectrum Disorders"&pic=https://cdn.suruga-ya.com/database/pics_webp/game/bo4001016.jpg.webp "share weibo")
Product description ※Please note that product information is not in full comprehensive meaning because of the machine translation.
Medicine
[Contents introduction]
In the MS / NMOSD area, changes in the concept of diseases, revision of diagnostic criteria, and development of new drugs are advancing at the Nisshin pace. Many changes that have occurred since the previous edition are carefully arranged and explained in an easy-to-understand manner.
Chapter I is a general content that takes up and explains the features of each disease, diagnostic algorithm, and therapeutic drug one by one. Chapter II takes up "important clinical issues" in which the response is divided even among specialists in the form of CQ-style. Chapter III introduces matters that can be understood to a certain extent among experts in the form of Q & A.